STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
NLTX NEOLEUKIN THERAPEUTICS INCORPORATED StockScouter® Report
9
StockScouter® Score
NEOLEUKIN THERAPEUTICS INCORPORATED, a micro cap company in the healthcare sector, is expected to outperform the market over the next six months with average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Earnings growth in the past year has accelerated rapidly compared to earnings growth in the past three years. Positive
- The multi-period measure of relative price change and consistency is above average. Positive/Neutral
- Moving average analysis for NLTX suggests flat price movement over the medium term. Neutral
Concerns
- Short-term relative price momentum exhibits meaningful weakness. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be in favor, stocks will be , and healthcare stocks will be in favor.
Expected Risk/Return
Core Model Grades
B
C
N/A
B